1. Lotz C, Muellenbach RM, Meybohm P, Mutlak H, Lepper PM, Rolfes C, Peivandi A, Stumpner J, Kredel M, Kranke P, Torje I, Reyher C. Effects of inhaled nitric oxide in COVID‐19–induced ARDS – Is it worthwhile? Acta Anaesthesiol Scand [Internet]. 2021 May 20;65(5):629–32. Available from: https://onlinelibrary.wiley.com/doi/10.1111/aas.13757
2. AbdelMassih AF, Ye J, Kamel A, Mishriky F, Ismail HA, Ragab HA, El Qadi L, Malak L, Abdu M, El-Husseiny M, Ashraf M, Hafez N, AlShehry N, El-Husseiny N, AbdelRaouf N, Shebl N, Hafez N, Youssef N, Afdal P, Hozaien R, Menshawey R, Saeed R, Fouda R. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection. Obesity Medicine. 2020.
3. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;
4. Åkerström S, Mousavi-Jazi M, Klingström J, Leijon M, Lundkvist A, Mirazimi A. Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus. J Virol [Internet]. 2005 Feb;79(3):1966–9. Available from: https://journals.asm.org/doi/10.1128/JVI.79.3.1966-1969.2005
5. Keyaerts E, Vijgen L, Chen L, Maes P, Hedenstierna G, Van Ranst M. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. Int J Infect Dis [Internet]. 2004 Jul;8(4):223–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1201971204000529
6. Tang DJ, Xu YH, Dai D, Han YJ, Wang BC, Lang YM, Liang Y, Zeng Y. Clinical analysis of four Chinese hemophiliacs with human immunodeficiency virus infection. Chin Med J (Engl) [Internet]. 1989 Nov;102(11):819–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2517721
7. Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol [Internet]. 1998 Feb;72(2):934–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9444985
8. Griffon B, Cillard J, Chevanne M, Morel I, Cillard P, Sergent O. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release. Hepatology [Internet]. 1998 Nov;28(5):1300–8. Available from: http://doi.wiley.com/10.1002/hep.510280519
9. Takhampunya R, Padmanabhan R, Ubol S. Antiviral action of nitric oxide on dengue virus type 2 replication. J Gen Virol [Internet]. 2006 Oct 1;87(10):3003–11. Available from: https://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.81880-0
10. Croen KD. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest [Internet]. 1993 Jun;91(6):2446–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8390481
11. Simon M, Falk KI, Lundkvist Å, Mirazimi A. Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus. Virus Res [Internet]. 2006 Sep;120(1–2):184–90. Available from: https://linkinghub.elsevier.com/retrieve/pii/S016817020600092X
12. Domachowske JB. Replication of respiratory syncytial virus is inhibited in target cells generating nitric oxide in situ. Front Biosci [Internet]. 2003;8(1):986. Available from: https://fbscience.com/Landmark/articles/10.2741/986
13. Banerjee NS, Moore DW, Wang H-K, Broker TR, Chow LT. NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions. Antiviral Res [Internet]. 2019 Oct;170:104559. Available from: http://www.ncbi.nlm.nih.gov/pubmed/104559
14. Bi Z, Reiss CS. Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol. 1995;69(4):2208–13.
15. Ormerod AD, White MI, Shah SA, Benjamin N. Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream. Br J Dermatol [Internet]. 1999 Dec;141(6):1051–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10606851
16. Lei C, Su B, Dong H, Fakhr BS, Grassi LG, Di Fenza R, Gianni S, Pinciroli R, Vassena E, Morais CCA, Bellavia A, Spina S, Kacmarek R, Berra L. Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19. medRxiv Prepr Serv Heal Sci. 2020;
17. Klingström J, Åkerström S, Hardestam J, Stoltz M, Simon M, Falk KI, Mirazimi A, Rottenberg M, Lundkvist Å. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur J Immunol [Internet]. 2006 Oct;36(10):2649–57. Available from: http://doi.wiley.com/10.1002/eji.200535587
18. Lei C, Su B, Dong H, Bellavia A, Di Fenza R, Fakhr BS, Gianni S, Grassi LG, Pinciroli R, Vassena E, Berra L. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). medRxiv Prepr Serv Heal Sci. 2020;
19. Akaberi D, Krambrich J, Ling J, Luni C, Hedenstierna G, Järhult JD, Lennerstrand J, Lundkvist Å. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol [Internet]. 2020 Oct;37:101734. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213231720309393
20. Saura M, Zaragoza C, McMillan A, Quick RA, Hohenadl C, Lowenstein JM, Lowenstein CJ. An Antiviral Mechanism of Nitric Oxide. Immunity [Internet]. 1999 Jan;10(1):21–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1074761300800035
21. Zell R, Markgraf R, Schmidtke M, Gorlach M, Stelzner A, Henke A, Sigusch HH, Gl�ck B. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice. Med Microbiol Immunol [Internet]. 2004 May 1;193(2–3):91–100. Available from: http://link.springer.com/10.1007/s00430-003-0198-6
22. Regev-Shoshani G, Vimalanathan S, McMullin B, Road J, Av-Gay Y, Miller C. Gaseous nitric oxide reduces influenza infectivity in vitro. Nitric oxide Biol Chem [Internet]. 2013 May 31;31:48–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23562771
23. Rimmelzwaan GF, Baars MM, de Lijster P, Fouchier RA, Osterhaus AD. Inhibition of influenza virus replication by nitric oxide. J Virol [Internet]. 1999 Oct;73(10):8880–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10482647
24. Lin YL, Huang YL, Ma SH, Yeh CT, Chiou SY, Chen LK, Liao CL. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol [Internet]. 1997 Jul;71(7):5227–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9188590
25. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem. 1992;267(23):16396–402.
26. Yamada M, Hayashi H, Yuuki M, Matsushima N, Yuan B, Takagi N. Furin inhibitor protects against neuronal cell death induced by activated NMDA receptors. Sci Rep. 2018;8(1).
27. Li H, Zhang LK, Li SF, Zhang SF, Wan WW, Zhang YL, Xin QL, Dai K, Hu YY, Wang ZB, Zhu XT, Fang YJ, Cui N, Zhang PH, Yuan C, Lu Q Bin, Bai JY, Deng F, Xiao GF, Liu W, Peng K. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res [Internet]. 2019;29(9):739–53. Available from: http://dx.doi.org/10.1038/s41422-019-0214-z
28. Van Hove CE, Van der Donckt C, Herman AG, Bult H, Fransen P. Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells. Br J Pharmacol [Internet]. 2009 Oct;158(3):920–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19788496
29. Argyropoulos K V., Serrano A, Hu J, Black M, Feng X, Shen G, Call M, Kim MJ, Lytle A, Belovarac B, Vougiouklakis T, Lin LH, Moran U, Heguy A, Troxel A, Snuderl M, Osman I, Cotzia P, Jour G. Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms. Am J Pathol [Internet]. 2020 Sep;190(9):1881–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S000294402030328X
30. Silva J, Lucas C, Sundaram M, Israelow B, Wong P, Klein J, Tokuyama M, Lu P, Venkataraman A, Liu F, Mao T, Oh JE, Park A, Casanovas-Massana A, Vogels CBF, Muenker CM, Zell J, Fournier JB, Campbell M, Chiorazzi M, Ruiz Fuentes E, Petrone M, Kalinich CC, Ott IM, Watkins A, Moore AJ, Nakahata MI, Grubaugh ND, Farhadian S, Dela Cruz C, Ko A, Schulz WL, Ring AM, Ma S, Omer S, Wyllie AL, Iwasaki A. Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality. medRxiv Prepr Serv Heal Sci [Internet]. 2021 Jan 10; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33442706